Evidence map›Paper›PMID 42729558›Full record

ArticleOncology letters2026

Clinical utility of circulating tumor-derived endothelial cells in lung cancer detection and prognosis prediction.

Xiang Li, Jun Yang, Bin Chen, Ziyu Zhang, Jiangman Zhao, Mengxin Zhao, Zhimou Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiang LiDepartment of Medical Oncology, 3201 Hospital, Hanzhong, Shaanxi 723000, P.R. China.
Jun YangDepartment of Oncology and Hematology II, Qinhuangdao Hospital of Integrated Traditional Chinese and Western Medicine, Hebei Port Group Co., Ltd., Qinhuangdao, Hebei 066005, P.R. China.
Bin ChenOncology, Radiology, Interventional and Radiotherapy Department, Lai'an County People's Hospital, Chuzhou, Anhui 239200, P.R. China.
Ziyu ZhangShanghai Biotecan Medical Laboratory Co., Ltd., Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Jiangman ZhaoShanghai Biotecan Medical Laboratory Co., Ltd., Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Mengxin ZhaoShanghai Biotecan Medical Laboratory Co., Ltd., Shanghai Zhangjiang Institute of Medical Innovation, Shanghai 201204, P.R. China.
Zhimou WangDepartment of Oncology and Hematology, People's Hospital of Xixiang County, Chengnan Sub-district Office, Hanzhong, Shaanxi 723508, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor-derived endothelial cells (CTEC) have emerged as promising biomarkers reflecting tumor angiogenesis, disease progression and therapeutic response, although their clinical relevance in lung cancer remains underexplored. A total of 74 patients with lung cancer were enrolled in the present study, and both preoperative and postoperative peripheral blood samples were collected. A total of 20 healthy individuals were included as controls. CTEC (CD31

Indexed as

circulating tumor cellcirculating tumor-derived endothelial celllung cancerSE-iFISH

Identifiers

PMID42729558
PMCPMC13563025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.